Clinical trial
PREVENT: a Prospective, Multi-center, Monitored Trial Investigating the Implant of the Promus Everolimus-Eluting Stent System in Critically Ischemic Lesions BTK
NCT01500070 is registered in ClinicalTrials.gov with Flanders Medical Research Program as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PREVENT: a Prospective, Multi-center, Monitored Trial Investigating the Implant of the Promus Everolimus-Eluting Stent System in Critically Ischemic Lesions BTK
- Lead sponsor
- Flanders Medical Research Program
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- August 31, 2012
- Completion date
- January 31, 2016
- Enrollment
- 70 (estimated)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.